![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, September 15, 2015 10:39:34 PM
Associate Director, Medi 4736
Employer AstraZeneca US
Location USA
Posted Sep 15, 2015
Closes Oct 13, 2015
Ref 15-ADIMMUNO
Result Type Jobs
Discipline Operations, Marketing
Position Type Permanent
Hours Full Time
Share
Apply
Role Description:
The Brand Strategy Associate Director, Medi-4736 will be accountable for leading the definition, design, execution and measurement of US brand strategy across both HCP & Patient segments for Medi-4736, AZ's first biologics launch in oncology. The role will require strong collaboration across brand and portfolio peers within the Lung Cancer Franchise team as well as Sales, Commercial Operations, Managed Markets, Diagnostics, and Alliance and Advocacy teams in order to deliver an integrated product launch plan. This position will report directly into the Brand Strategy Director, I-O Portfolio.
This position is based at our Gaithersburg, MD campus, headquarters for our US Oncology and other Specialty Care businesses as well as the US Commercial Center for multiple Therapeutic Areas of our Global Product and Portfolio Strategy businesses.
Major Responsibilities:
* Responsible for leading the following key work: marketing strategies (PSP), brand positioning, core messaging and campaign, sales integration, and ROI analysis
* Partners with the Brand Insight Director on the planning of all insight work (primary and secondary research, database management, ROI measurements, etc.)
* Works closely with portfolio marketing team to ensure successful implementation of Medi-4736 product strategy and achievement of channel goals
* Primary daily lead with sales teams to monitor performance, ensure message pull through and uncover opportunities and issues in execution.
* Partners with Managed Markets to produce a value story and pricing model.
* Collaborate with other functional areas to ensure promotional planning is consistent with legal/regulatory compliance
* Participates in development of training for field/customer service personnel on brand information
* Lead partnership efforts with Global Brand Team to share learning's, initiatives and also incorporate insights from other marketing companies and global initiatives
Requirements
THIS REQ IS FOR FUTURE OPENINGS ONLY
Minimum Requirements:
Bachelor's Degree in relevant field
7 years of pharmaceutical or Healthcare; preferrably related experience
3 years Brand Management experience
Experience in working collaboratively, thinking strategically, complex project management
Experience developing a strategy and executing on that strategy
Preferred Requirements:
MBA in relevant field
Experience in other commercial roles such as Managed Markets, Market Research, and Sales
Pharmaceuticals launch experience
Oncology and/or specialty care biologics experience
Recent CDMO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:40:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 12:23:26 AM
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
FEATURED Element79 Gold Corp Appoints Warren Levy to Board of Directors • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM